• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Absence of new thymidine-associated mutations and evidence of an immune virologic response over a 12-month period in a cohort of antiretroviral-experienced HIV-1-infected subjects treated with tenofovir combination therapy.

作者信息

Lo Cicero Mirko, Bulgheroni Elisabetta, Soster Francesca, Viganò Ottavia, Cicconi Paola, Galli Massimo, Rusconi Stefano

出版信息

J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):238-41. doi: 10.1097/01.qai.0000178409.62675.f9.

DOI:10.1097/01.qai.0000178409.62675.f9
PMID:16186745
Abstract
摘要

相似文献

1
Absence of new thymidine-associated mutations and evidence of an immune virologic response over a 12-month period in a cohort of antiretroviral-experienced HIV-1-infected subjects treated with tenofovir combination therapy.
J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):238-41. doi: 10.1097/01.qai.0000178409.62675.f9.
2
Predictors of selection of K65R: tenofovir use and lack of thymidine analogue mutations.K65R选择的预测因素：替诺福韦的使用和无胸苷类似物突变
AIDS. 2004 Oct 21;18(15):2094-6. doi: 10.1097/00002030-200410210-00018.
3
Virologic and immunologic efficacy of the tenofovir/didanosine/lamivudine regimen.替诺福韦/去羟肌苷/拉米夫定方案的病毒学和免疫学疗效。
J Acquir Immune Defic Syndr. 2006 Jul;42(3):389-90. doi: 10.1097/01.qai.0000225018.35643.d9.
4
[Tenofovir DF in rescue regimens].
Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:25-30. doi: 10.1157/13126269.
5
Patterns of resistance emerging in HIV-1 from antiretroviral-experienced patients undergoing intensification therapy with tenofovir disoproxil fumarate.接受富马酸替诺福韦二吡呋酯强化治疗的抗逆转录病毒治疗经验丰富的HIV-1患者中出现的耐药模式。
J Acquir Immune Defic Syndr. 2004 Nov 1;37(3):1340-50. doi: 10.1097/00126334-200411010-00002.
6
HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.南部非洲的 HIV-HBV 合并感染以及拉米夫定与替诺福韦为基础的 cART 对 HBV 结局的影响。
J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):174-82. doi: 10.1097/QAI.0b013e3182a60f7d.
7
Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients.两种新型抗逆转录病毒核苷类似物固定剂量配方的近期可得性：一项针对初治和经治患者对其实际应用及治疗前景的为期12个月的前瞻性开放标签调查。
AIDS Patient Care STDS. 2008 Apr;22(4):279-90. doi: 10.1089/apc.2007.0141.
8
An open-label pilot study to determine the efficacy of lopinavir/ritonavir and tenofovir DF in the treatment of HIV-infected patients experiencing first virologic failure on a non-nucleoside-based regimen.一项开放标签的试点研究，以确定洛匹那韦/利托那韦和替诺福韦酯在治疗对非核苷类方案首次出现病毒学失败的HIV感染患者中的疗效。
AIDS Patient Care STDS. 2008 Apr;22(4):263-6. doi: 10.1089/apc.2007.0148.
9
Compromised immunologic recovery in patients receiving tipranavir/ritonavir coadministered with tenofovir and didanosine in Randomized Evaluation of Strategic Intervention in multidrug-resiStant patients with tipranavir (RESIST) studies.在随机评估替拉那韦对多重耐药患者的策略性干预（RESIST）研究中，接受替拉那韦/利托那韦与替诺福韦和去羟肌苷联合给药的患者免疫恢复受损。
J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):479-81. doi: 10.1097/QAI.0b013e318061b76e.
10
Tenofovir disoproxil fumarate for the treatment of HIV infection.替诺福韦酯用于治疗HIV感染。
Expert Opin Drug Metab Toxicol. 2006 Jun;2(3):459-69. doi: 10.1517/17425255.2.3.459.